Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Francis F Lee. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Francis F Lee har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:IOTS / Adesto Technologies Corporation | Director | 0 |
US:SYNA / Synaptics Incorporated | Director | 31 687 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Francis F Lee. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Francis F Lee som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2020-07-01 |
|
4 | IOTS |
ADESTO TECHNOLOGIES Corp
Director Stock Option (right to buy) |
D - Sale to Issuer | −3 030 | 0 | −100,00 | ||||
2020-07-01 |
|
4 | IOTS |
ADESTO TECHNOLOGIES Corp
Common Stock |
U - Other | −27 848 | 0 | −100,00 | 12,55 | −349 492 | ||
2019-11-05 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
A - Award | 4 294 | 31 687 | 15,68 | ||||
2019-06-06 |
|
4 | IOTS |
ADESTO TECHNOLOGIES Corp
Common Stock |
A - Award | 7 662 | 27 848 | 37,96 | ||||
2019-01-17 |
|
4 | SYNA |
SYNAPTICS Inc
Director Stock Option (Right to Buy) |
M - Exercise | −6 000 | 0 | −100,00 | ||||
2019-01-17 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
M - Exercise | 6 000 | 27 393 | 28,05 | 23,16 | 138 960 | 634 422 | |
2018-11-15 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
A - Award | 5 218 | 21 393 | 32,26 | ||||
2018-07-31 |
|
4 | IOTS |
ADESTO TECHNOLOGIES Corp
Common Stock |
A - Award | 3 243 | 20 186 | 19,14 | ||||
2018-06-22 |
|
4 | SYNA |
SYNAPTICS Inc
Director Stock Option (Right to Buy) |
M - Exercise | −28 125 | 0 | −100,00 | ||||
2018-06-22 |
|
4 | SYNA |
SYNAPTICS Inc
Employee Stock Option (Right to Buy) |
M - Exercise | −63 141 | 0 | −100,00 | ||||
2018-06-22 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
S - Sale | X | −32 323 | 16 175 | −66,65 | 54,54 | −1 762 799 | 882 136 |
2018-06-22 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
S - Sale | X | −158 943 | 48 498 | −76,62 | 54,05 | −8 591 457 | 2 621 496 |
2018-06-22 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
M - Exercise | 28 125 | 207 441 | 15,68 | 24,20 | 680 625 | 5 020 072 | |
2018-06-22 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
M - Exercise | 63 141 | 179 316 | 54,35 | 24,33 | 1 536 221 | 4 362 758 | |
2018-06-11 |
|
4 | SYNA |
SYNAPTICS Inc
Employee Stock Option (Right to Buy) |
M - Exercise | −63 141 | 63 141 | −50,00 | ||||
2018-06-11 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
S - Sale | X | −89 275 | 95 380 | −48,35 | 45,00 | −4 017 375 | 4 292 100 |
2018-06-11 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
S - Sale | X | −63 141 | 47 069 | −57,29 | 46,00 | −2 904 486 | 2 165 174 |
2018-06-11 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
M - Exercise | 63 141 | 110 210 | 134,15 | 24,33 | 1 536 221 | 2 681 409 | |
2018-05-21 |
|
4 | SYNA |
SYNAPTICS Inc
Employee Stock Option (Right to Buy) |
M - Exercise | −20 000 | 126 282 | −13,67 | ||||
2018-05-21 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
S - Sale | X | −20 000 | 47 069 | −29,82 | 43,00 | −860 000 | 2 023 967 |
2018-05-21 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
M - Exercise | 20 000 | 67 069 | 42,49 | 24,33 | 486 600 | 1 631 789 | |
2018-05-15 |
|
4 | SYNA |
SYNAPTICS Inc
Employee Stock Option (Right to Buy) |
M - Exercise | −7 385 | 146 282 | −4,81 | ||||
2018-05-15 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
S - Sale | X | −7 385 | 47 069 | −13,56 | 43,03 | −317 760 | 2 025 276 |
2018-05-15 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
M - Exercise | 7 385 | 54 454 | 15,69 | 24,33 | 179 677 | 1 324 866 | |
2018-05-14 |
|
4 | SYNA |
SYNAPTICS Inc
Director Stock Option (Right to Buy) |
M - Exercise | −6 000 | 0 | −100,00 | ||||
2018-05-14 |
|
4 | SYNA |
SYNAPTICS Inc
Employee Stock Option (Right to Buy) |
M - Exercise | −41 333 | 153 667 | −21,20 | ||||
2018-05-14 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
S - Sale | X | −200 | 47 069 | −0,42 | 45,12 | −9 024 | 2 123 753 |
2018-05-14 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
S - Sale | X | −6 200 | 47 269 | −11,60 | 44,23 | −274 238 | 2 090 802 |
2018-05-14 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
S - Sale | X | −40 933 | 53 469 | −43,36 | 43,20 | −1 768 171 | 2 309 684 |
2018-05-14 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
M - Exercise | 6 000 | 94 402 | 6,79 | 32,53 | 195 180 | 3 070 897 | |
2018-05-14 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
M - Exercise | 41 333 | 88 402 | 87,81 | 24,33 | 1 005 632 | 2 150 821 | |
2018-01-24 |
|
4 | SYNA |
SYNAPTICS Inc
Director Stock Option (Right to Buy) |
M - Exercise | −144 900 | 0 | −100,00 | ||||
2018-01-24 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
M - Exercise | 144 900 | 181 965 | 390,93 | 15,55 | 2 253 195 | 2 829 556 | |
2018-01-18 |
|
4 | SYNA |
SYNAPTICS Inc
Director Stock Option (Right to Buy) |
M - Exercise | −100 | 144 900 | −0,07 | ||||
2018-01-18 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
S - Sale | X | −100 | 49 759 | −0,20 | 50,00 | −5 000 | 2 487 950 |
2018-01-18 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
M - Exercise | 100 | 49 859 | 0,20 | 15,55 | 1 555 | 775 307 | |
2017-11-02 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
A - Award | 5 378 | 49 759 | 12,12 | ||||
2017-06-09 |
|
4 | SYNA |
SYNAPTICS Inc
Director Stock Option (Right to Buy) |
M - Exercise | −6 000 | 0 | −100,00 | ||||
2017-06-09 |
|
4 | SYNA |
SYNAPTICS Inc
Director Stock Option (Right to Buy) |
M - Exercise | −50 000 | 145 000 | −25,64 | ||||
2017-06-09 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
S - Sale | X | −56 000 | 45 533 | −55,15 | 60,00 | −3 360 157 | 2 732 107 |
2017-06-09 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
M - Exercise | 6 000 | 101 533 | 6,28 | 26,74 | 160 440 | 2 714 992 | |
2017-06-09 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
M - Exercise | 50 000 | 95 533 | 109,81 | 15,55 | 777 500 | 1 485 538 | |
2017-06-08 |
|
4 | IOTS |
ADESTO TECHNOLOGIES Corp
Restricted Stock Units |
M - Exercise | −8 241 | 0 | −100,00 | ||||
2017-06-08 |
|
4 | IOTS |
ADESTO TECHNOLOGIES Corp
Common Stock |
A - Award | 6 250 | 16 943 | 58,45 | ||||
2017-06-08 |
|
4 | IOTS |
ADESTO TECHNOLOGIES Corp
Common Stock |
M - Exercise | 8 241 | 10 693 | 336,09 | ||||
2017-01-17 |
|
4 | SYNA |
SYNAPTICS Inc
Director Stock Option (Right to Buy) |
M - Exercise | −44 375 | 0 | −100,00 | ||||
2017-01-17 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
M - Exercise | 44 375 | 46 685 | 1 921,00 | 19,63 | 871 081 | 916 427 | |
2016-11-10 |
|
4 | IOTS |
ADESTO TECHNOLOGIES Corp
Restricted Stock Units |
M - Exercise | −2 452 | 0 | −100,00 | ||||
2016-11-10 |
|
4 | IOTS |
ADESTO TECHNOLOGIES Corp
Common Stock |
M - Exercise | 1 226 | 2 452 | 100,00 | ||||
2016-11-01 |
|
4 | SYNA |
SYNAPTICS Inc
Director Stock Option (Right to Buy) |
A - Award | 2 900 | 2 900 | |||||
2016-11-01 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
A - Award | 2 304 | 2 310 | 38 400,00 | ||||
2016-06-08 |
|
4 | IOTS |
ADESTO TECHNOLOGIES Corp
Restricted Stock Units |
A - Award | 8 241 | 8 241 | |||||
2015-11-06 |
|
4 | SYNA |
SYNAPTICS Inc
Director Stock Option (Right to Buy) |
M - Exercise | −20 000 | 44 375 | −31,07 | ||||
2015-11-06 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
S - Sale | X | −5 781 | 1 683 | −77,45 | 91,39 | −528 303 | 153 803 |
2015-11-06 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
S - Sale | X | −14 219 | 7 464 | −65,58 | 90,21 | −1 282 638 | 673 297 |
2015-11-06 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
M - Exercise | 20 000 | 21 683 | 1 188,35 | 19,63 | 392 600 | 425 637 | |
2015-11-03 |
|
4 | IOTS |
ADESTO TECHNOLOGIES Corp
Restricted Stock Units |
A - Award | 2 452 | 2 452 | |||||
2015-10-27 |
|
4 | SYNA |
SYNAPTICS Inc
Director Stock Option (Right to Buy) |
A - Award | 2 302 | 2 302 | |||||
2015-10-27 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
A - Award | 1 677 | 2 011 | 502,10 | ||||
2015-10-13 |
|
4 | SYNA |
SYNAPTICS Inc
Director Stock Option (Right to Buy) |
M - Exercise | −20 000 | 64 375 | −23,70 | ||||
2015-10-13 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
S - Sale | X | −20 000 | 334 | −98,36 | 85,05 | −1 701 056 | 28 408 |
2015-10-13 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
M - Exercise | 20 000 | 20 334 | 5 988,02 | 19,63 | 392 600 | 399 156 | |
2015-06-01 |
|
4 | SYNA |
SYNAPTICS Inc
Director Stock Option (Right to Buy) |
M - Exercise | −11 750 | 0 | −100,00 | ||||
2015-06-01 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
S - Sale | X | −9 213 | 32 429 | −22,12 | 99,99 | −921 208 | 3 242 576 |
2015-06-01 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
S - Sale | X | −4 000 | 661 | −85,82 | 100,00 | −400 000 | 66 100 |
2015-06-01 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
S - Sale | X | −7 750 | 4 661 | −62,44 | 99,99 | −774 922 | 466 053 |
2015-06-01 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
M - Exercise | 11 750 | 12 411 | 1 777,61 | 20,47 | 240 522 | 254 053 | |
2015-05-26 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
S - Sale | X | −10 000 | 41 642 | −19,36 | 94,99 | −949 900 | 3 955 574 |
2015-05-26 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
G - Gift | −22 422 | 0 | −100,00 | ||||
2015-05-26 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
G - Gift | −22 422 | 0 | −100,00 | ||||
2015-05-26 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
G - Gift | −10 000 | 22 422 | −30,84 | ||||
2015-05-26 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
G - Gift | −10 000 | 22 422 | −30,84 | ||||
2015-05-19 |
|
4 | SYNA |
SYNAPTICS Inc
Director Stock Option (Right to Buy) |
M - Exercise | −13 800 | 11 750 | −54,01 | ||||
2015-05-19 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
S - Sale | X | −7 825 | 51 642 | −13,16 | 90,00 | −704 262 | 4 647 857 |
2015-05-19 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
S - Sale | X | −13 800 | 661 | −95,43 | 90,00 | −1 241 934 | 59 487 |
2015-05-19 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
M - Exercise | 13 800 | 14 461 | 2 087,75 | 20,47 | 282 486 | 296 017 | |
2015-05-13 |
|
4 | SYNA |
SYNAPTICS Inc
Director Stock Option (Right to Buy) |
M - Exercise | −1 200 | 25 550 | −4,49 | ||||
2015-05-13 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
S - Sale | X | −2 175 | 59 467 | −3,53 | 89,99 | −195 728 | 5 351 435 |
2015-05-13 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
S - Sale | X | −1 200 | 661 | −64,48 | 89,99 | −107 988 | 59 483 |
2015-05-13 |
|
4 | SYNA |
SYNAPTICS Inc
Common Stock |
M - Exercise | 1 200 | 1 861 | 181,54 | 20,47 | 24 564 | 38 095 | |
2015-04-29 |
|
4 | SYNA |
SYNAPTICS INC
Director Stock Option (Right to Buy) |
M - Exercise | −82 000 | 26 750 | −75,40 | ||||
2015-04-29 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −10 000 | 61 314 | −14,02 | 85,25 | −852 536 | 5 227 239 |
2015-04-29 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −11 766 | 989 | −92,25 | 85,68 | −1 008 106 | 84 737 |
2015-04-29 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −70 234 | 12 755 | −84,63 | 85,11 | −5 977 461 | 1 085 550 |
2015-04-29 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
M - Exercise | 82 000 | 82 989 | 8 291,20 | 20,47 | 1 678 540 | 1 698 785 | |
2015-01-27 |
|
4 | SYNA |
SYNAPTICS INC
Director Stock Option (Right to Buy) |
M - Exercise | −10 000 | 108 750 | −8,42 | ||||
2015-01-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −10 000 | 1 316 | −88,37 | 67,50 | −675 000 | 88 830 |
2015-01-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
M - Exercise | 10 000 | 11 316 | 759,88 | 20,47 | 204 700 | 231 639 | |
2015-01-05 |
|
4 | SYNA |
SYNAPTICS INC
Director Stock Option (Right to Buy) |
M - Exercise | −20 000 | 118 750 | −14,41 | ||||
2015-01-05 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −20 000 | 1 316 | −93,83 | 65,54 | −1 310 800 | 86 251 |
2015-01-05 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
M - Exercise | 20 000 | 21 316 | 1 519,76 | 20,47 | 409 400 | 436 339 | |
2014-10-28 |
|
4 | SYNA |
SYNAPTICS INC
Director Stock Option (Right to Buy) |
A - Award | 2 400 | 2 400 | |||||
2014-10-28 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
A - Award | 1 310 | 1 941 | 207,61 | ||||
2014-06-13 |
|
4 | SYNA |
SYNAPTICS INC
Director Stock Option (Right to Buy) |
M - Exercise | −10 000 | 138 750 | −6,72 | ||||
2014-06-13 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −10 000 | 1 256 | −88,84 | 77,33 | −773 300 | 97 126 |
2014-06-13 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
M - Exercise | 10 000 | 11 256 | 796,18 | 20,47 | 204 700 | 230 410 | |
2014-04-28 |
|
4 | SYNA |
SYNAPTICS INC
Director Stock Option (Right to Buy) |
M - Exercise | −10 000 | 148 750 | −6,30 | ||||
2014-04-28 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −300 | 1 881 | −13,76 | 67,57 | −20 271 | 127 099 |
2014-04-28 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −9 700 | 2 181 | −81,64 | 67,50 | −654 750 | 147 218 |
2014-04-28 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
M - Exercise | 10 000 | 11 881 | 531,63 | 20,47 | 204 700 | 243 204 | |
2014-04-23 |
|
4 | SYNA |
SYNAPTICS INC
Director Stock Option (Right to Buy) |
M - Exercise | −10 000 | 158 750 | −5,93 | ||||
2014-04-23 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −10 000 | 1 881 | −84,17 | 65,00 | −650 000 | 122 265 |
2014-04-23 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
M - Exercise | 10 000 | 11 881 | 531,63 | 20,47 | 204 700 | 243 204 | |
2014-01-16 |
|
4 | SYNA |
SYNAPTICS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2014-01-16 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −2 000 | 2 506 | −44,39 | 55,03 | −110 060 | 137 905 |
2014-01-16 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −2 500 | 4 506 | −35,68 | 55,02 | −137 550 | 247 920 |
2014-01-16 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −434 | 7 006 | −5,83 | 55,01 | −23 874 | 385 400 |
2014-01-16 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −15 066 | 7 440 | −66,94 | 55,00 | −828 630 | 409 200 |
2014-01-16 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
M - Exercise | 20 000 | 22 506 | 798,08 | 20,17 | 403 400 | 453 946 | |
2014-01-09 |
|
4 | SYNA |
SYNAPTICS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −20 000 | 20 000 | −50,00 | ||||
2014-01-09 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −20 000 | 2 506 | −88,87 | 52,50 | −1 050 000 | 131 565 |
2014-01-09 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
M - Exercise | 20 000 | 22 506 | 798,08 | 20,17 | 403 400 | 453 946 | |
2014-01-06 |
|
4 | SYNA |
SYNAPTICS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −28 475 | 40 000 | −41,58 | ||||
2014-01-06 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −10 475 | 2 506 | −80,69 | 51,19 | −536 215 | 128 282 |
2014-01-06 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −940 | 12 981 | −6,75 | 50,51 | −47 479 | 655 670 |
2014-01-06 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −700 | 13 921 | −4,79 | 50,50 | −35 350 | 703 010 |
2014-01-06 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −1 258 | 14 621 | −7,92 | 50,40 | −63 403 | 736 898 |
2014-01-06 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −1 000 | 15 879 | −5,92 | 50,30 | −50 300 | 798 714 |
2014-01-06 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −360 | 16 879 | −2,09 | 50,22 | −18 079 | 847 663 |
2014-01-06 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −2 000 | 17 239 | −10,40 | 50,21 | −100 420 | 865 570 |
2014-01-06 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −900 | 19 239 | −4,47 | 50,16 | −45 144 | 965 028 |
2014-01-06 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −2 100 | 20 139 | −9,44 | 50,15 | −105 315 | 1 009 971 |
2014-01-06 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −2 000 | 22 239 | −8,25 | 50,07 | −100 140 | 1 113 507 |
2014-01-06 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −2 000 | 24 239 | −7,62 | 50,05 | −100 100 | 1 213 162 |
2014-01-06 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −2 742 | 26 239 | −9,46 | 50,00 | −137 100 | 1 311 950 |
2014-01-06 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −2 000 | 28 981 | −6,46 | 49,94 | −99 880 | 1 447 311 |
2014-01-06 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
M - Exercise | 28 475 | 30 981 | 1 136,27 | 20,17 | 574 341 | 624 887 | |
2013-11-27 |
|
4 | SYNA |
SYNAPTICS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −20 000 | 68 475 | −22,61 | ||||
2013-11-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −20 000 | 2 506 | −88,87 | 50,00 | −1 000 000 | 125 300 |
2013-11-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
M - Exercise | 20 000 | 22 506 | 798,08 | 20,17 | 403 400 | 453 946 | |
2013-11-13 |
|
4 | SYNA |
SYNAPTICS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −20 000 | 88 475 | −18,44 | ||||
2013-11-13 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −20 000 | 2 506 | −88,87 | 47,50 | −950 000 | 119 035 |
2013-11-13 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
M - Exercise | 20 000 | 22 506 | 798,08 | 20,17 | 403 400 | 453 946 | |
2013-10-30 |
|
4 | SYNA |
SYNAPTICS INC
Director Stock Option (Right to Buy) |
A - Award | 4 500 | 4 500 | |||||
2013-10-30 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
A - Award | 2 500 | 5 506 | 83,17 | ||||
2013-09-27 |
|
4 | SYNA |
SYNAPTICS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −30 000 | 108 475 | −21,66 | ||||
2013-09-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −200 | 3 006 | −6,24 | 45,07 | −9 014 | 135 480 |
2013-09-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −400 | 3 206 | −11,09 | 45,06 | −18 024 | 144 462 |
2013-09-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −300 | 3 606 | −7,68 | 45,04 | −13 512 | 162 414 |
2013-09-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −1 507 | 3 906 | −27,84 | 45,03 | −67 860 | 175 887 |
2013-09-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −27 593 | 5 413 | −83,60 | 45,00 | −1 241 685 | 243 585 |
2013-09-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
M - Exercise | 30 000 | 33 006 | 998,00 | 20,17 | 605 100 | 665 731 | |
2013-05-13 |
|
4 | SYNA |
SYNAPTICS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −30 000 | 138 475 | −17,81 | ||||
2013-05-13 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −30 000 | 3 006 | −90,89 | 42,50 | −1 275 000 | 127 755 |
2013-05-13 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
M - Exercise | 30 000 | 33 006 | 998,00 | 20,17 | 605 100 | 665 731 | |
2013-05-06 |
|
4 | SYNA |
SYNAPTICS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −23 966 | 168 475 | −12,45 | ||||
2013-05-06 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −3 966 | 3 006 | −56,88 | 40,29 | −159 790 | 121 112 |
2013-05-06 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −30 800 | 6 972 | −81,54 | 40,43 | −1 245 112 | 281 848 |
2013-05-06 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
M - Exercise | 23 966 | 37 772 | 173,59 | 20,17 | 483 394 | 761 861 | |
2013-05-06 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
M - Exercise | 10 800 | 13 806 | 359,28 | 10,93 | 118 044 | 150 900 | |
2013-05-06 |
|
4 | SYNA |
SYNAPTICS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −12 559 | 192 441 | −6,13 | ||||
2013-05-06 |
|
4 | SYNA |
SYNAPTICS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −20 672 | 10 800 | −65,68 | ||||
2013-05-06 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −16 981 | 3 006 | −84,96 | 40,00 | −679 240 | 120 240 |
2013-05-06 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −16 250 | 19 987 | −44,84 | 39,02 | −634 075 | 779 893 |
2013-05-06 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
M - Exercise | 12 559 | 36 237 | 53,04 | 20,17 | 253 315 | 730 900 | |
2013-05-06 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
M - Exercise | 20 672 | 23 678 | 687,69 | 10,93 | 225 945 | 258 801 | |
2013-05-06 |
|
4 | SYNA |
SYNAPTICS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −10 800 | 0 | −100,00 | ||||
2012-11-02 |
|
4 | SYNA |
SYNAPTICS INC
Director Stock Option (Right to Buy) |
A - Award | 6 000 | 6 000 | |||||
2012-11-02 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
A - Award | 3 000 | 3 006 | 50 000,00 | ||||
2012-02-27 |
|
4 | SYNA |
SYNAPTICS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −20 000 | 205 000 | −8,89 | ||||
2012-02-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −10 000 | 32 422 | −23,57 | 37,50 | −375 000 | 1 215 825 |
2012-02-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −300 | 32 422 | −0,92 | 37,71 | −11 313 | 1 222 634 |
2012-02-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −300 | 32 422 | −0,92 | 37,71 | −11 313 | 1 222 634 |
2012-02-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −9 700 | 32 722 | −22,87 | 37,50 | −363 750 | 1 227 075 |
2012-02-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −2 500 | 62 787 | −3,83 | 37,70 | −94 250 | 2 367 070 |
2012-02-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −700 | 65 287 | −1,06 | 37,69 | −26 383 | 2 460 667 |
2012-02-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −100 | 65 987 | −0,15 | 37,67 | −3 767 | 2 485 730 |
2012-02-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −100 | 66 087 | −0,15 | 37,66 | −3 766 | 2 488 836 |
2012-02-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −2 207 | 66 187 | −3,23 | 37,65 | −83 094 | 2 491 941 |
2012-02-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −6 593 | 68 394 | −8,79 | 37,64 | −248 161 | 2 574 350 |
2012-02-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −100 | 74 987 | −0,13 | 37,60 | −3 760 | 2 819 511 |
2012-02-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −600 | 75 087 | −0,79 | 37,59 | −22 554 | 2 822 520 |
2012-02-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −300 | 75 687 | −0,39 | 37,55 | −11 265 | 2 842 047 |
2012-02-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −400 | 75 987 | −0,52 | 37,54 | −15 016 | 2 852 552 |
2012-02-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −200 | 76 387 | −0,26 | 37,51 | −7 502 | 2 865 276 |
2012-02-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −5 900 | 76 587 | −7,15 | 37,50 | −221 250 | 2 872 012 |
2012-02-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
M - Exercise | 20 000 | 82 487 | 32,01 | 20,17 | 403 400 | 1 663 763 | |
2009-10-27 |
|
4 | SYNA |
SYNAPTICS INC
Director Stock Options (Right to Buy) |
A - Award | 28 125 | 28 125 | |||||
2009-10-27 |
|
4 | SYNA |
SYNAPTICS INC
Common Stock |
A - Award | 14 213 | 194 348 | 7,89 | ||||
2008-11-12 |
|
4/A | SYNA |
SYNAPTICS INC
Common Stock |
F - Taxes | −628 | 167 290 | −0,37 | 30,89 | −19 399 | 5 167 588 | |
2008-11-12 |
|
4/A | SYNA |
SYNAPTICS INC
Common Stock |
F - Taxes | −418 | 167 918 | −0,25 | 30,89 | −12 912 | 5 186 987 | |
2007-09-05 |
|
4/A | SYNA |
SYNAPTICS INC
Common Stock |
M - Exercise | 3 692 | 79 269 | 4,89 | 1,00 | 3 692 | 79 269 | |
2006-06-13 |
|
4/A | SYNA |
SYNAPTICS INC
Common Stock |
M - Exercise | 60 000 | 69 233 | 649,84 | 1,00 | 60 000 | 69 233 | |
2006-01-25 |
|
4/A | SYNA |
SYNAPTICS INC
Employee Stock Option (Right to Buy) |
M - Exercise | −20 000 | 170 000 | −10,53 | ||||
2006-01-25 |
|
4/A | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −8 678 | 8 810 | −49,62 | 27,88 | −241 943 | 245 623 |
2006-01-25 |
|
4/A | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −658 | 17 488 | −3,63 | 27,85 | −18 325 | 487 041 |
2006-01-25 |
|
4/A | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −442 | 18 146 | −2,38 | 27,81 | −12 292 | 504 640 |
2006-01-25 |
|
4/A | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −400 | 18 588 | −2,11 | 27,80 | −11 120 | 516 746 |
2006-01-25 |
|
4/A | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −100 | 18 988 | −0,52 | 27,77 | −2 777 | 527 297 |
2006-01-25 |
|
4/A | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −100 | 19 088 | −0,52 | 27,76 | −2 776 | 529 883 |
2006-01-25 |
|
4/A | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −200 | 19 188 | −1,03 | 27,75 | −5 550 | 532 467 |
2006-01-25 |
|
4/A | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −100 | 19 388 | −0,51 | 27,74 | −2 774 | 537 823 |
2006-01-25 |
|
4/A | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −100 | 19 488 | −0,51 | 27,71 | −2 771 | 540 012 |
2006-01-25 |
|
4/A | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −400 | 19 588 | −2,00 | 27,68 | −11 072 | 542 196 |
2006-01-25 |
|
4/A | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −400 | 19 988 | −1,96 | 27,65 | −11 060 | 552 668 |
2006-01-25 |
|
4/A | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −400 | 20 388 | −1,92 | 27,60 | −11 040 | 562 709 |
2006-01-25 |
|
4/A | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −600 | 20 788 | −2,81 | 27,56 | −16 536 | 572 917 |
2006-01-25 |
|
4/A | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −100 | 21 388 | −0,47 | 27,55 | −2 755 | 589 239 |
2006-01-25 |
|
4/A | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −7 222 | 21 488 | −25,15 | 27,51 | −198 677 | 591 135 |
2006-01-25 |
|
4/A | SYNA |
SYNAPTICS INC
Common Stock |
S - Sale | X | −100 | 28 710 | −0,35 | 27,50 | −2 750 | 789 525 |
2006-01-25 |
|
4/A | SYNA |
SYNAPTICS INC
Common Stock |
M - Exercise | 20 000 | 28 810 | 227,01 | 9,00 | 180 000 | 259 290 |